Search Results
FDA approval offers hope for prevention of acute graft-versus-host disease
First pediatric drug approval for prevention of graft-versus-host disease
Graft-versus-Host Disease: Advances in Prevention and Treatment
Abatacept for prevention of acute GVHD
Graft versus Host Disease Advances and Challenges in Prevention and Treatment
Overcoming the Challenges of Acute and Chronic GVHD
Overcoming GVHD Is the Key to Better HCT Outcomes: Guidance on Managing Acute and Chronic Disease
New Perspectives in Acute and Chronic GVHD
GVHD in 2022: from prevention to therapy
Repurposing drugs for the treatment of acute GvHD
Dr David Snyder on Responses to Ruxolitinib in Patients With Acute GVHD
Towards personalized therapy for chronic GvHD
